Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Bio Gaia Biologics AB (OTC: BGAIF).

Full DD Report for BGAIF

You must become a subscriber to view this report.


Recent News from (OTC: BGAIF)

BioGaia AB - Year-end report 2017
STOCKHOLM , Feb. 8, 2018 /PRNewswire/ -- Comments from the Managing Director:  "2017 was yet another successful year for BioGaia. With growth of 15%, we were able to boost our sales by SEK 80 million and achieve an annual turnover of SEK 615 million . We have thus continued ou...
Source: PR Newswire
Date: February, 08 2018 02:15

 


About Bio Gaia Biologics AB (OTC: BGAIF)

Logo for Bio Gaia Biologics AB (OTC: BGAIF)

Not available

 

Contact Information

     

     

    Current Share Structure

    • Market Cap: $771,138,029 - 05/11/2018
    • Issue and Outstanding: 16,530,290 - 12/22/2011

     


    Recent Filings from (OTC: BGAIF)

    Filing to become effective immediately upon filing
    Filing Type: F-6EFFiling Source: edgar
    Filing Date: June, 30 2017

     

     


    Daily Technical Chart for (OTC: BGAIF)

    Daily Technical Chart for (OTC: BGAIF)


    Stay tuned for daily updates and more on (OTC: BGAIF)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: BGAIF)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    OTC Report
    @OTCReporter

     

     


    Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BGAIF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of BGAIF and does not buy, sell, or trade any shares of BGAIF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/